Hypermethylation of the pl 6 INK 4 a Promoter in Colectomy Specimens of Patients with Long-standing and Extensive Ulcerative Colitis 1 ' 2
暂无分享,去创建一个
[1] K. Ohtsubo,et al. Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] J. Herman,et al. Association between CpG island methylation and microsatellite instability in colorectal cancer. , 1997, Cancer research.
[3] C. Moskaluk,et al. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. , 1997, Cancer research.
[4] C. Sherr. Cancer Cell Cycles , 1996, Science.
[5] Carissa A. Sanchez,et al. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. , 1996, Oncogene.
[6] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[7] Carissa A. Sanchez,et al. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. , 1996, Oncogene.
[8] R. Beart,et al. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.
[9] J. Herman,et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.
[10] Kathleen R. Cho,et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours , 1995, Nature Genetics.
[11] J. Herman,et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.
[12] A. Ekbom. Cancer in inflammatory bowel disease , 1995 .
[13] M. Skolnick,et al. A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.
[14] G. Hannon,et al. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.
[15] Rudolf Jaenisch,et al. Role for DNA methylation in genomic imprinting , 1993, Nature.
[16] M. Kimmey,et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. , 1992, Gastroenterology.
[17] F. Borchard,et al. DNA aneuploidy in Crohn's disease and ulcerative colitis: results of a comparative flow cytometric study. , 1992, Gut.
[18] D. Ransohoff,et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.
[19] I. Christensen,et al. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. , 1983, Cytometry.
[20] E. Campo,et al. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. , 1997, Blood.
[21] F. Haluska,et al. Suppressor Gene in Melanocytic Lesions Correlates with Invasive Stage of Tumor Progression1 , 1995 .